Optimizing Expression Systems for AAV Vectors: Optimizing AAV vector manufacturing will be necessary to meet anticipated future market demand.
| Publicado en: | BioPharm International Vol. 37; no. 7; pp. 18 - 21 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Jul/Aug2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179074688&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 179074688 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1542166X 5NE jtl: BioPharm International issn: 1542166X maglogo: N pubinfo: dt: Jul/Aug2024 vid: 37 iid: 7 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 179074688 179074688 179074688 179074688 ppf: 18 ppct: 3 formats: fmt: @attributes: type: P tig: atl: Optimizing Expression Systems for AAV Vectors: Optimizing AAV vector manufacturing will be necessary to meet anticipated future market demand. aug: au: MIRASOL, FELIZA sug: subj: Pharmaceutical Companies Manufacturing Industry Viruses Gene Therapy Proteins Cell Line Biotechnology Technology, Pharmaceutical Sterilization and Disinfection Methods Microbial Contamination Prevention and Control Cross Infection Prevention and Control pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|